| NCT07095075 | A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases | NOT_YET_RECRUITING | EARLY_PHASE1 | 2025-09-20 | 2029-12-31 | 2029-12-31 |
| NCT07100067 | LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma | NOT_YET_RECRUITING | NA | 2025-08-20 | 2029-11-20 | 2028-02-20 |
| NCT07049081 | A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases | RECRUITING | PHASE1 | 2025-07-17 | 2030-04-30 | 2028-04-30 |
| NCT06866080 | A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases | WITHDRAWN | EARLY_PHASE1 | 2025-06-17 | 2025-06-17 | 2025-06-17 |
| NCT05680922 | DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer | RECRUITING | PHASE1 | 2023-07-26 | 2028-03 | 2028-01 |
| NCT05539430 | Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma | RECRUITING | PHASE1 | 2023-04-18 | 2027-12 | 2027-12 |
| NCT04712864 | Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-09-13 | 2025-12 | 2023-12 |
| NCT03758417 | A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-01-23 | 2025-10-20 | 2025-07-10 |
| NCT03090659 | LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma | UNKNOWN | PHASE1, PHASE2 | 2015-10-02 | 2023-12-31 | 2023-12-31 |